DMT PLUS: Ayahuasca Ingredients Point to a Vast, Untapped Domain of Healing Molecules

In case you hadn’t heard, the “medicinal psychedelics industry” is growing furiously, with over 150 clinical trials underway. Hardly a week goes by without a new university center, startup or venture funding announcement. Almost all within just the last 5 years. A sign of the times: the NIH just awarded $4 million to Johns Hopkins Center for Psychedelics and Consciousness Research while $10 million was directed into NYU Langone for investigation into psychedelics for example.

On the other side of the country, now touts its very own “Psilocybin Services” office. The Office will start taking applications on January 2, 2023 for the first legally operated clinics for taking psychedelics in a controlled setting (outside FDA-licensed trial sites). (Zoom listening sessions are open to the public from December 13, 14 and 15. Open licenses include Service Center and Training Program).

Surge in Research

Where Psilocybin goes, DMT and Ayahuasca can’t be far behind. A flurry of activity indicates a surge in research and the potential of new treatments.

BioMind Labs, based in Toronto, has develope...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee